BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//hacksw/handcal//NONSGML v1.0//EN
CALSCALE:GREGORIAN
X-WR-TIMEZONE:America/New_York
BEGIN:VEVENT
LOCATION:
SUMMARY:Addressing the Social and Behavioral Drivers of Prescribing
DESCRIPTION:About this On Demand Training\n\nCost: Free\nDate: Thursday\, 
 September 1\, 2022\; 1:00pm-2:15pm ET\nThis course is open for 
 Pre-registration. Content will be available in 
 August.\nAddressing the Social and Behavioral Drivers of 
 Prescribing: Innovative Approaches to Antibiotic 
 Stewardship Join NCQA for a discussion about the 
 integration of social and behavioral science principles into 
 antibiotic stewardship. Speakers will highlight the impact 
 of social factors on antibiotic prescribing and share 
 practical\, evidence based\, real-world strategies that 
 address these factors. This session will highlight a novel 
 antibiotic stewardship program to improve clinician 
 communication practices to address patient expectations for 
 antibiotics.   \nParticipants will learn the importance 
 of considering the social and behavioral drivers of 
 antibiotic prescribing in the design and implementation of 
 improvement interventions. They will learn about 
 evidence-based communication strategies clinicians can use 
 to avoid inappropriate antibiotic prescribing and increase 
 satisfaction with care.  Participants will be able to ask 
 live questions about these topics.\nWhat You Will 
 Learn\n\nDescribe the social and behavioral factors that 
 influence antibiotic prescribing Understand the importance 
 of using implementation strategies to promote the uptake of 
 antibiotic stewardship across contexts Describe key 
 communication strategies clinicians can use to decrease 
 inappropriate antibiotic prescribing and increase 
 satisfaction during visits for acute respiratory 
 infections Who Should Attend\n\nHealth care 
 professionals Health care decision 
 makers Consultants Health plans Health systems Health 
 centers/health practices Hospitals Population health 
 organizations Federal and state government 
 agencies Faculty\n\n\nRita Mangione-Smith\, MD\, MPHRita 
 Mangione-Smith\, MD\, MPH\, was appointed Vice President for 
 Research and Health Care Innovation at Kaiser Permanente 
 Washington and Executive Director of Kaiser Permanente 
 Washington Health Research Institute (KPWHRI) in August 
 2019. She is also a Professor in the Department of Health 
 Systems Science at Kaiser Permanente Bernard J. Tyson School 
 of Medicine. Before joining Kaiser Permanente Washington\, 
 Dr. Mangione-Smith served as Professor and Chief of the 
 Division of General Pediatrics and Hospital Medicine at the 
 University of Washington Department of Pediatrics and as an 
 Investigator in the Center for Child Health\, Behavior\, and 
 Development at Seattle Children’s Research Institute.\nAs 
 an NIH and AHRQ funded Senior Investigator at KPWHRI\, Dr. 
 Mangione-Smith’s research primarily focuses on assessing 
 pediatric quality of care and then developing\, implementing\, 
 and rigorously evaluating quality improvement interventions 
 in areas such as hospital-to-home care transitions\, 
 hospital-based mental health care\, and inpatient care for 
 respiratory illnesses. Over the past twenty years\, she has 
 also conducted extensive research on doctor-parent 
 communication\, studying how interactions influence the 
 decision to prescribe antibiotics for acute respiratory 
 tract illness in pediatric outpatient settings. Based on 
 this work\, she developed an evidence-based\, multifaceted 
 quality improvement intervention for outpatient providers 
 called Dialogue Around Respiratory Illness treatment (DART). 
 In a clinical trial conducted under funding from NICHD\, the 
 DART program was found to be highly effective in preventing 
 inappropriate antibiotic prescribing for acute respiratory 
 tract illnesses. This effective QI program has been broadly 
 adopted on a national scale.\nIn 2018\, AcademyHealth honored 
 Dr. Mangione-Smith with its “Child Health Interest Group 
 Lifetime Achievement Award\,” recognizing her significant 
 and lasting contributions to child health services research. 
 She also received the 2017 Academic Pediatric Association 
 Research Award\, the organization’s highest award for 
 research excellence and achievement.\n \n\nJulia E. 
 Szymczak\, PhDJulia Szymczak is an Assistant Professor of 
 Epidemiology and Medicine (Infectious Diseases) at the 
 University of Pennsylvania’s Perelman School of Medicine. 
 Dr. Szymczak is a medical sociologist with expertise in the 
 social and cultural determinants of decision-making and 
 behavior in healthcare organizations. She is an 
 internationally recognized expert on the sociobehavioral 
 dynamics that shape antimicrobial use across clinical 
 contexts in human and veterinary medicine and in the 
 application of implementation science frameworks to research 
 in antimicrobial stewardship. Her research on antimicrobials 
 and stewardship has been funded by AHRQ\, CDC and PCORI and 
 her peer-reviewed scholarship has appeared in high impact 
 clinical and social science journals. She is the recipient 
 of the 2020 SHEA Research Scholar Award and a newly 
 appointed Voting Member on the Presidential Advisory Council 
 on Combating Antibiotic-Resistant Bacteria (PACCARB). In 
 addition to her research\, Dr. Szymczak serves as the 
 Associate Director for Social Science Methods in Healthcare 
 Delivery Science at The Children's Hospital of Philadelphia 
 (CHOP) and is an Associate Editor of BMJ Quality and Safety. 
 She is also an award-winning teacher and mentor\, who strives 
 to train clinical scholars in social science theory-informed 
 methodology to improve the delivery of healthcare. She 
 completed a Postdoctoral Fellowship in the Division of 
 Infectious Diseases at CHOP\, holds Ph.D. and M.A. degrees in 
 sociology from the University of Pennsylvania and a B.A. in 
 sociology\, summa cum laude\, from Brandeis 
 University.\n \n\nModerator: Nancy McGee\, MS\, MBANancy A. 
 McGee is an Assistant Director in the Research and Analysis 
 Department at the National Committee for Quality Assurance 
 (NCQA). She is responsible for the development and 
 maintenance of HEDIS measures primarily addressing geriatric 
 health care. She has also worked on research efforts focused 
 on person-driven outcomes for individuals with serious 
 illness\, multiple chronic conditions and 
 disabilities.\nPrior to joining NCQA\, Ms. McGee worked in 
 employee benefits\, including as a benefits manager for a 
 national employee organization\; as a Health and Benefits 
 Consultant for Mercer\; and as a Project Manager implementing 
 benefits administration systems for ADP and Ceridian.\nMs. 
 McGee has an MS in Gerontology from the University of Utah 
 School of Nursing and an MBA from the David Eccles School of 
 Business at the University of Utah.\nContinuing 
 Education\n\n\nIn support of improving patient care\, the 
 National Committee for Quality Assurance is jointly 
 accredited by the Accreditation Council for Continuing 
 Medical Education (ACCME)\, the Accreditation Council for 
 Pharmacy Education (ACPE)\, the American Nurses Credentialing 
 Center (ANCC) to provide Interprofessional Continuing 
 Education for the healthcare team. \nThis educational 
 activity is approved for a maximum of 1.0 AMA PRA Category 
 1 Credit™. \nThis educational activity is approved for 
 1.0 nursing contact hours.*\nThe assigned universal program 
 number: JA0004597-0000-22-019-L04-P. Upon successful 
 completion of this program (attending the full session and 
 completing a program evaluation)\, participants will access 
 CPE Monitor on the ACPE website to locate and track their 
 CPE statement of credit.\nThis live course grants 1.0 
 Continuing Education Unit (CEU) points for PCMH Certified 
 Content Experts.  \n* Please note – You must attend 
 the entire program to be eligible for total number of 
 contact hours.\nNABP Credit Reporting If you are a 
 pharmacist completing a course offering CPE credits\, please 
 notify NCQA through ncqa.org within 14 calendar days that 
 you have completed a CPE course. You must provide the title 
 of the course\, your NABP identification number and your DOB 
 (month/date) within the notification to NCQA. We also 
 recommend you update your education.ncqa.org profile with 
 your NABP identification number.  \nDisclosure of Relevant 
 Financial RelationshipsThe National Committee for Quality 
 Assurance (NCQA) endorses the Standards of the Accreditation 
 Council for Continuing Medical Education which specify that 
 sponsors of continuing medical education activities and 
 presenters at and planners for these activities disclose any 
 relevant financial relationships either party might have 
 with commercial companies whose products or services are 
 discussed in educational presentations.\nFor sponsors\, 
 relevant financial relationships include large research 
 grants\, institutional agreements for joint initiatives\, 
 substantial gifts\, or other relationships that benefit the 
 institution.  For presenters or planning committee members\, 
 relevant financial relationships include the receipt of 
 research grants from a commercial company\, consultancies\, 
 honoraria\, travel\, or other benefits\, or having a 
 self-managed equity interest in a company\; or having an 
 immediate family member or partner with such a 
 relationship.\nDisclosure of a relationship is not intended 
 to suggest or condone bias in any presentation but is made 
 to provide participants with information that might be of 
 potential importance to their evaluation of a 
 presentation.\nRelevant financial relationships exist with 
 the following companies/organizations:\nFaculty:\nRita 
 Mangione-Smith : None\nJulie Szymczak: None\nAdditional 
 Planning Committee Members:\nCathy Beckner: None\nNancy 
 McGee: None\nSepheen Byron: Dr. Byron received funding from 
 the Centers for Disease Control and Prevention (contract no. 
 75D30120C08243) to develop the measure related to antibiotic 
 utilization.\nThis program was developed in part by NCQA 
 staff.\nAcknowledgement\nSupport for this project was 
 provided by The Pew Charitable Trusts.\nDisclaimer\n“The 
 views expressed are those of the author(s) and do not 
 necessarily reflect the views of The Pew Charitable 
 Trusts”.\n
DTSTART:20220318T000000
DTEND:20230902T235900
URL;VALUE=URI:
DTSTAMP:20260527T221337
UID:6a17a4d1deef8
END:VEVENT
END:VCALENDAR